SCHEMBL23809146

SCHEMBL23809146

Cc1nc(COCc2ccccc2)nc(C)c1C(C)(C)C

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.41
KDM4E B2RXH2 1/20 0.39
POLB P06746 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
STAT3 P40763 1/20 0.38
HTT P42858 1/20 0.38
ALDH1A1 P00352 1/20 0.36
CSNK1D P48730 1/20 0.36
RAB9A P51151 1/20 0.35
SLC6A2 P23975 1/20 0.35
TAAR1 Q96RJ0 1/20 0.35
AR P10275 1/20 0.35
GHSR Q92847 1/20 0.35
MAPT P10636 1/20 0.35
MAPK1 P28482 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CA1 P00915 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26580967 0.83 TSHR (0.56) TSHRL3MBTL1SMN1; SMN2STAT3HTT
SCHEMBL26037955 0.80 TSHR (0.52) TSHRL3MBTL1KDM4ESMN1; SMN2STAT3
SCHEMBL20604774 0.80 TSHR (0.52) TSHRL3MBTL1SMN1; SMN2STAT3HTT
SCHEMBL20604722 0.76 TSHR (0.47) TSHRL3MBTL1KDM4EPOLBSMN1; SMN2
SCHEMBL29091864 0.72 TSHR (0.94) TSHRKDM4EPOLBALDH1A1SLC6A2
SCHEMBL20605133 0.71 DGAT1 (0.41) TSHRL3MBTL1SMN1; SMN2STAT3HTT
Tert-Butanol SCHEMBL27883617 0.70 TSHR (0.71) TSHRKDM4EPOLBALDH1A1SLC6A2
SCHEMBL26328836 0.70 TSHR (0.58) TSHRL3MBTL1KDM4EPOLBSMN1; SMN2
SCHEMBL27380 0.70 TSHR (1.00) TSHRKDM4EPOLBALDH1A1SLC6A2
SCHEMBL5311581 0.70 TSHR (1.00) TSHRKDM4EPOLBALDH1A1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3423435-B1 SUBSTITUTED INDOLE MCL-1 INHIBITORS UNIV VANDERBILT (US) 2023-08-23 EP disclosed
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2021-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS MCL1, BCL2L1, BCL9 TSHR 4309/4885L3MBTL1 135/4885KDM4E 1156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.